Condition
Skin Microbiota
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Unknown1
Completed1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07454525Not ApplicableNot Yet Recruiting
Examine Impact of Topical Application of Active Versus Placebo on the Skin Microbiome in Sensitive Skin.
NCT04845672Not ApplicableUnknownPrimary
Comparison of the Permanent Skin Flora of Children Who Had Bathing With Two Different Products
NCT01148667Phase 4Completed
Lactobacillus Rhamnosus GG: Interaction With Human Microbiota and Immunity
Showing all 3 trials